With most Americans delaying or skipping new COVID-19 booster shots, analysts and investors are now predicting far fewer will be given each year, pushing the number of shots well below annual flu vaccinations.
could have to hike prices as much as three times current levels if they hope to meet Wall Street revenue forecasts for the shots for 2023 and beyond, several analysts said.
He added that instances of COVID infections in those who have been vaccinated has left many to question the effectiveness of the vaccine. Uptake of the boosters this year in the European Union did not spike as hoped after new, updated shots that target Omicron were released, staying in a range of 1 million to 1.4 million doses a week.
The companies could make up for some of the weaker demand with price increases. Moderna has said that it could aim to charge as much as $100 a dose for shots that it originally priced at around $16.50.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA OKs Novavax COVID Vaccine as First Booster ShotOn Wednesday, the FDA approved Novavax Inc.'s protein-based vaccine as a first booster dose. Until now, it had only been approved as a two-dose primary series.
Read more »
COVID-19 linked to US pregnancy-related deaths; Pence's populist warning; Disney's price hikesThings to know today: COVID-19 linked to increase in US pregnancy-related deaths; Pence warns of 'unprincipled populists'; Disney price hikes.
Read more »
COVID-19 linked to US pregnancy-related deaths; Pence's populist warning; Disney's price hikesThings to know today: COVID-19 linked to increase in US pregnancy-related deaths; Pence warns of 'unprincipled populists'; Disney price hikes.
Read more »
Philadelphia Orchestra cancels upcoming 50th-anniversary China tourDaily News | Philadelphia Orchestra cancels upcoming 50th-anniversary China tour
Read more »
US clears Novavax COVID booster doseThe Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax.
Read more »